REG - CVS Group plc - SAYE Option Scheme & PDMR Dealing
25/11/2022 16:30
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221125:nRSY6817Ha&default-theme=true
RNS Number : 6817H CVS Group plc 25 November 2022
25 November 2022
CVS Group plc
("CVS" or the "Company")
Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing
CVS Group plc (the "Company") announces that as part of its 2022/2023 Save As
You Earn share scheme (the "SAYE Scheme"), which is open to all employees of
the Group, the Executive Directors named below have elected to participate in
the SAYE Scheme and have been granted SAYE Scheme options as follows:
Richard Fairman 380 SAYE
scheme options
Robin Alfonso 403
SAYE scheme options
Ben Jacklin 403 SAYE scheme
options
Eligible employees were invited to subscribe for options over the Company's
ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price
of 1,515 pence per share, representing a 20% discount to the average closing
middle market price for the three dealing days prior to 1 November 2022, being
the invitation date.
In response to accepted invitations, a total of 381,689 SAYE Scheme options
over Ordinary Shares were granted on 25 November 2022, equating to 0.54% of
the current issued ordinary share capital. Subject to the rules of the SAYE
Scheme, these options will be capable of exercise from the maturity date on 1
January 2026.
The notification below, made in accordance with the requirements of UK MAR,
provides further detail.
Contacts:
CVS Group
plc
via Camarco
Richard Fairman, CEO
Jenny Farrer, Group Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker)
+44 (0)20
7418 8900
Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose
Berenberg (Joint Broker)
+44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial
PR)
Geoffrey Pelham-Lane
+44
(0)7733 124 226
Ginny Pulbrook
+44 (0)7961 315 138
Toby Strong
+44 (0)7789 151 644
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Richard Fairman
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name CVS Group plc
b) LEI 213800J41XDQ2NX48O05
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over Ordinary shares of 0.2 pence each
Identification code
GB00B2863827
b) Nature of the transaction Grant of Options under the SAYE Scheme.
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price of 1,515p 380
d) Aggregated information
- Aggregated volume
- Price
e) Date of the transaction 25 November 2022
f) Place of the transaction Off market
d)
Aggregated information
- Aggregated volume
- Price
e)
Date of the transaction
25 November 2022
f)
Place of the transaction
Off market
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Robin Alfonso
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name CVS Group plc
b) LEI 213800J41XDQ2NX48O05
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over Ordinary shares of 0.2 pence each
Identification code
GB00B2863827
b) Nature of the transaction Grant of Options under the SAYE Scheme.
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price of 1,515p 403
d) Aggregated information
- Aggregated volume
- Price
e) Date of the transaction 25 November 2022
f) Place of the transaction Off market
d)
Aggregated information
- Aggregated volume
- Price
e)
Date of the transaction
25 November 2022
f)
Place of the transaction
Off market
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Ben Jacklin
2 Reason for the notification
a) Position/status Chief Operating Officer
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name CVS Group plc
b) LEI 213800J41XDQ2NX48O05
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options over Ordinary shares of 0.2 pence each
Identification code
GB00B2863827
b) Nature of the transaction Grant of Options under the SAYE Scheme.
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price of 1,515p
403
d) Aggregated information
- Aggregated volume
- Price
e) Date of the transaction 25 November 2022
f) Place of the transaction Off market
d)
Aggregated information
- Aggregated volume
- Price
e)
Date of the transaction
25 November 2022
f)
Place of the transaction
Off market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHPPGBGGUPPGQARecent news on CVS
See all newsREG - CVS Group plc - Total Voting Rights
AnnouncementREG - CVS Group plc - Disposal of Crematorium Operations
AnnouncementREG - CVS Group plc - Total Voting Rights
AnnouncementREG - CVS Group plc - PDMR Dealing
AnnouncementREG - CVS Group plc - Standard form for notification of major holdings
Announcement